Evidence map›Paper›PMID 36283746›Full record

ArticleLupus science & medicine2022

Health information use by patients with systemic lupus erythematosus (SLE) pre and during the COVID-19 pandemic.

Francesca S Cardwell, Susan J Elliott, Ricky Chin, Yvan St Pierre, May Y Choi, Murray B Urowitz, Guillermo Ruiz-Irastorza, Sasha Bernatsky, Daniel J Wallace, Michelle A Petri and 23 more

Open access · goldAbstract read
In one paragraph

Article in Lupus science & medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Stepping into the Void: Lessons Learned from Civil Society Organizations during COVID-19 in Rio de Janeiro.International journal of environmental research and public health · 2023
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors at 20 institutions in 9 countries.

Francesca S CardwellGeography and Environmental Management, University of Waterloo, Waterloo, Ontario, Canada fcardwel@uwaterloo.ca.ORCID 0000-0002-7393-466X
Susan J ElliottGeography and Environmental Management, University of Waterloo, Waterloo, Ontario, Canada.
Ricky ChinDivision of Rheumatology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Yvan St PierreDivision of Clinical Epidemiology, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada.
May Y ChoiDivision of Rheumatology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.ORCID 0000-0003-3760-2737
Murray B UrowitzSchroeder Arthritis Institute, Kremblin Research Institute, University of Toronto, Toronto, Ontario, Canada.ORCID 0000-0001-7506-9166
Guillermo Ruiz-IrastorzaAutoimmune Diseases Research Unit, BioCruces Bizkaia Health Research Institute, University of the Basque Country, Barakaldo, Bizkaia, Spain.ORCID 0000-0001-7788-1043
Sasha BernatskyDepartment of Medicine and Centre for Outcomes Research & Evaluation, McGill University, Montreal, Quebec, Canada.ORCID 0000-0002-9515-2802
Daniel J WallaceRheumatology, Cedars-Sinai Medical Center, West Hollywood, California, USA.ORCID 0000-0002-2502-1372
Michelle A PetriDivision of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0003-1441-5373
Susan ManziLupus Center of Excellence, Allegheny Health Network, Pittsburgh, Pennsylvania, USA.ORCID 0000-0002-0803-6150
Sang-Cheol BaeDepartment of Rheumatology, Hanyang University Seoul Hospital, Seoul, The Republic of Korea.ORCID 0000-0003-4658-1093
Jung-Min ShinDepartment of Rheumatology, Hanyang University, Seongdong-gu, Seoul, The Republic of Korea.
Anselm MakDepartment of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.ORCID 0000-0002-4688-7829
Jiacai ChoDepartment of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.ORCID 0000-0002-4477-3430
Christine A PeschkenMax Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
Rosalind Ramsey-GoldmanFeinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Paul R FortinMedicine-Rheumatology, Centre Hospitalier de l'Université Laval, Quebec City, Quebec, Canada.ORCID 0000-0002-7278-2596
John G HanlyDivision of Rheumatology, Department of Medicine, Queen Elizabeth II Health Sciences Center and Dalhousie University, Halifax, Nova Scotia, Canada.ORCID 0000-0003-1029-9483
Bernardo A Pons-EstelRheumatology, Centro Regional de Enfermedades Autoinmunes y Reumáticas (CREAR), Rosario, Argentina.ORCID 0000-0003-2518-0266
Romina NietoDepartment of Rheumatology, Centro Regional de Enfermedades Autoinmunes y Reumáticas (CREAR), Rosario, Argentina.
Anca D AskanaseColumbia University Medical Center, New York, New York, USA.ORCID 0000-0003-4597-5023
Juanita Romero-DiazImmunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Marta MoscaDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Ian N BruceArthritis Research UK Centre for Epidemiology, The University of Manchester, Manchester, UK.ORCID 0000-0003-3047-500X
Leigha RowbottomDivision of Rheumatology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Leanne MielczarekLupus Canada, Newmarket, Ontario, Canada.
Karin TseLupus Foundation of America Inc, Washington, District of Columbia, USA.
Ashley MarionLupus Foundation of America Inc, Washington, District of Columbia, USA.
Juan Carlos Cáhiz-GonzálezFederación Española de Lupus, Madrid, Spain.
Teresa G CattoniAsociación Lupus Argentina, Buenos Aires, Argentina.
Alain CornetLupus Europe, Brussels, Belgium.ORCID 0000-0001-7344-7258
Ann Elaine ClarkeDivision of Rheumatology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
University of Calgary · CAHospital Provincial de Rosario · ARLupus Foundation of America · USNational University of Singapore · SGUniversity of Waterloo · CAAllegheny Health Network · USCedars-Sinai Medical Center · USCentre hospitalier de l'Université Laval · CAColumbia University Irving Medical Center · USDalhousie University · CAFederación Española de Enfermedades Raras · ESHanyang University · KRHanyang University Seoul Hospital · KRInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán · MXJohns Hopkins University · USMcGill University · CAMcGill University Health Centre · CANorthwestern University · USSystems, Applications & Products in Data Processing (Canada) · CAUniversity of Manchester · GB

Funding

Northwestern University Clinical and Translational Science Institute (NUCATS)UL1TR001422 · NCATS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI D'AQUILA, RICHARD · 2015 to 2023
$56.8M
MULTIDISCIPLINARY CLINICAL AND TRANSLATIONAL SCIENCE (MCTS) PROGRAM (UL1)UL1RR025741 · NCRR · NORTHWESTERN UNIVERSITY AT CHICAGO · PI GREENLAND, PHILIP · 2008 to 2011
$24.7M
Study of Lupus Vascular and Bone Longterm EndpointsP60AR048098 · NIAMS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI PASCHE, BORIS · 2002 to 2011
$11.4M
Resource CoreP30AR072579 · NIAMS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Leena Sharma · 2017 to 2026
$8.3M
Lupus CohortR01AR043727 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI PETRI, MICHELLE A · 1997 to 2015
$8.2M
Physical Activity Changes & Thersholds: Quality of Life and Outcomes in Knee OAP60AR064464 · NIAMS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI SHARMA, LEENA · 2013 to 2017
$4.5M
Hopkins Lupus CohortR01AR069572 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI PETRI, MICHELLE A · 2016 to 2020
$3.4M
NCATS NIH HHS UL1 TR001422NCRR NIH HHS UL1 RR025741NIAMS NIH HHS P30 AR072579NIAMS NIH HHS P60 AR048098NIAMS NIH HHS P60 AR064464NIAMS NIH HHS R01 AR043727NIAMS NIH HHS R01 AR069572
6 · The paper itself

Abstract

objectiveWe conducted an international survey of patients with SLE to assess their access, preference and trust in various health information sources pre-COVID-19 and during the COVID-19 pandemic.

methodsPatients with SLE were recruited from 18 observational cohorts, and patients self-reporting SLE were recruited through five advocacy organisations. Respondents completed an online survey from June 2020 to December 2021 regarding the sources of health information they accessed in the 12 months preceding (pre-11 March 2020) and during (post-11 March 2020) the pandemic. Multivariable logistic regressions assessed factors associated with accessing news and social media post-11 March 2020, and self-reporting negative impacts from health information accessed through these sources.

resultsSurveys were completed by 2111 respondents; 92.8% were female, 76.6% had postsecondary education, mean (SD) age was 48.8 (14.0) years. Lupus specialists and family physicians were the most preferred sources pre-11 March 2020 and post-11 March 2020, yet were accessed less frequently (specialists: 78.5% pre vs 70.2% post, difference -8.3%, 95% CI -10.2% to -6.5%; family physicians: 57.1% pre vs 50.0% post, difference -7.1%, 95% CI -9.2% to -5.0%), while news (53.2% pre vs 62.1% post, difference 8.9%, 95% CI 6.7% to 11.0%) and social media (38.2% pre vs 40.6% post, difference 2.4%, 95% CI 0.7% to 4.2%) were accessed more frequently post-11 March 2020 vs pre-11 March 2020. 17.2% of respondents reported negative impacts from information accessed through news/social media. Those outside Canada, older respondents or with postsecondary education were more likely to access news media. Those in Asia, Latin America or younger respondents were more likely to access social media. Those in Asia, older respondents, males or with postsecondary education in Canada, Asia or the USA were less likely to be negatively impacted.

conclusionsPhysicians, the most preferred and trusted sources, were accessed less frequently, while news and social media, less trusted sources, were accessed more frequently post-11 March 2020 vs pre-11 March 2020. Increasing accessibility to physicians, in person and virtually, may help reduce the consequences of accessing misinformation/disinformation.

Indexed as

COVID-19Lupus Erythematosus, SystemicSocial MediaFemaleHumansMaleMass MediaMiddle AgedPandemicsCOVID-19health services researchlupus erythematosus, systemic

Identifiers

PMID36283746
PMCPMC9606736
OpenAlexW4307497502

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.